Skip to navigation menu Skip to content
Clinical Trial Search block Test

New-Onset Refractory Status Epilepticus

NORSE

  • Phase: N/A

What is the goal of the study?

The purpose of this study is to contribute to the establishment of a collection of health-related data and biological samples that will enable researchers to understand the cause of cryptogenic new-onset refractory status epilepticus (NORSE), to identify the key determinants of outcome and to determine the best management strategy.

Who can participate in the study?

Everyone

Study Team: